ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.4223
-0.0379 (-8.24%)
At close: May 9, 2025, 4:00 PM
0.4220
-0.0003 (-0.07%)
After-hours: May 9, 2025, 7:49 PM EDT
ALX Oncology Holdings Stock Forecast
ALXO's stock price has decreased by -97.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ALX Oncology Holdings stock have an average target of 3.54, with a low estimate of 1.50 and a high estimate of 9.00. The average target predicts an increase of 738.27% from the current stock price of 0.42.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ALX Oncology Holdings stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5 → $2 | Strong Buy | Maintains | $5 → $2 | +373.60% | May 9, 2025 |
| Stifel | Stifel | Hold Maintains $3 → $1.5 | Hold | Maintains | $3 → $1.5 | +255.20% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +1,083.99% | Mar 7, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +2,031.19% | Mar 6, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $3 | Hold → Strong Buy | Upgrades | $2 → $3 | +610.40% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.75
from -2.58
EPS Next Year
-1.48
from -1.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | 61.4M | ||
| Avg | n/a | n/a | 23.5M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.42 | -1.18 | -0.44 |
| Avg | -1.75 | -1.48 | -1.20 |
| Low | -2.11 | -1.95 | -1.97 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.